Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TICTAC Trial: Tacrolimus In Combination vs Tacrolimus Alone in Heart Transplant
NCT00299221Phase 4Completed
- Sponsor
- Newark Beth Israel Medical Center
- Start
- Apr 2004
- Primary completion
- Jun 2009
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus, mycophenolate mofetil in graft rejection, sponsored by Newark Beth Israel Medical Center. Started Apr 2004; status: completed.
02
Drugs
tacrolimusmycophenolate mofetil
03
Conditions
graft rejection
Beyond the preview
Go deeper on NCT00299221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299221.